Author: Dino Mustafić

March 15, 2021 Off

Roche buys genMak for $1.8 billion

By Dino Mustafić

Roche is buying GenMark at a price of US$ 24.05 per share in an all-cash transaction, the companies announced Monday agreement with a total transaction value of approximately US$ 1.8 billion.

February 18, 2021 Off

Navamedics revenues up 17% in Q4 2020

By Dino Mustafić

Navamedic ASA said Thursday it grew revenues by 17% in the fourth quarter of 2020 compared to the same quarter last year, as it reported revenues of NOK 55.3 million in the fourth quarter of 2020 with an EBITDA of negative NOK 3.7 (€5.4) million driven by both new product launches and investments in further growth initiatives.